We report the characterization of a CAAT enhancer-binding protein (C/EBP) (NF-IL6) element encompassing the region from -174 to -166 of the U3 long terminal repeat (LTR) region of HIV-1. This C/EBP cis sequence was found to bind to C/EBP beta and C/EBP delta factors in DNA band shift assay. Transfection of NTera-2 cells with a HIV-1-LTR CAT construct (pC15CAT), together with C/EBP beta or C/EBP delta expression plasmids showed that C/EBP proteins strongly activated the HIV-1 promoter. Deletions encompassing the C/EBP-binding site resulted in the enhancement of the LTR activation mediated by C/EBP proteins, suggesting that other sequences located 3' to -170 were indeed the target for C/EBP factors, This possibility was confirmed by using the pCD54E9CAT plasmid, in which the NF-kappa B enhancer was inserted 5' to the HIV-1 LTR TATA box. A NF-kappa B1(p50) expression plasmid was also utilized to test for functional co-operation between NF-kappa B and C/EBP factors. We observed that p50 . C/EBP beta and p50 . C/EBP delta complexes were generated in tested cells and strongly activated the HIV-1 LTR by binding to the NF-kappa B sequences, The physical association of NF-kappa B1(p50) with C/EBP factors was assayed by direct interaction of in vitro translated p50 proteins with C/EBP beta or C/EBP delta produced as glutathione S-transferase fusion proteins. Moreover, p50 . C/EBP beta complexes were observed in vivo by using DNA affinity studies with biotinylated NF-kappa B oligonucleotides. By using mutant forms of p50 or C/EBP beta proteins we found that the transactivation of HIV-1 LTR by p50 . C/EBP beta complexes required the DNA-binding domain of p50 and the transcription activation domain of C/EBP beta.
Regulation of HIV-1 long terminal repeats by interaction of C:EBP(NF-IL6) and NF-kB/Rel transcription factors / Ruocco, MARIA ROSARIA; Chen, X.; Ambrosino, C.; Dragonetti, E.; Liu, W.; Mallardo, M.; DE FALCO, G.; Palmieri, C.; Franzoso, G.; Quinto, I.; Venuta, S.; Scala, G.. - In: THE JOURNAL OF BIOLOGICAL CHEMISTRY. - ISSN 0021-9258. - STAMPA. - 271:37(1996), pp. 22479-22486. [10.1074/jbc.271.37.22479]
Regulation of HIV-1 long terminal repeats by interaction of C:EBP(NF-IL6) and NF-kB/Rel transcription factors.
RUOCCO, MARIA ROSARIA;M. MALLARDO;
1996
Abstract
We report the characterization of a CAAT enhancer-binding protein (C/EBP) (NF-IL6) element encompassing the region from -174 to -166 of the U3 long terminal repeat (LTR) region of HIV-1. This C/EBP cis sequence was found to bind to C/EBP beta and C/EBP delta factors in DNA band shift assay. Transfection of NTera-2 cells with a HIV-1-LTR CAT construct (pC15CAT), together with C/EBP beta or C/EBP delta expression plasmids showed that C/EBP proteins strongly activated the HIV-1 promoter. Deletions encompassing the C/EBP-binding site resulted in the enhancement of the LTR activation mediated by C/EBP proteins, suggesting that other sequences located 3' to -170 were indeed the target for C/EBP factors, This possibility was confirmed by using the pCD54E9CAT plasmid, in which the NF-kappa B enhancer was inserted 5' to the HIV-1 LTR TATA box. A NF-kappa B1(p50) expression plasmid was also utilized to test for functional co-operation between NF-kappa B and C/EBP factors. We observed that p50 . C/EBP beta and p50 . C/EBP delta complexes were generated in tested cells and strongly activated the HIV-1 LTR by binding to the NF-kappa B sequences, The physical association of NF-kappa B1(p50) with C/EBP factors was assayed by direct interaction of in vitro translated p50 proteins with C/EBP beta or C/EBP delta produced as glutathione S-transferase fusion proteins. Moreover, p50 . C/EBP beta complexes were observed in vivo by using DNA affinity studies with biotinylated NF-kappa B oligonucleotides. By using mutant forms of p50 or C/EBP beta proteins we found that the transactivation of HIV-1 LTR by p50 . C/EBP beta complexes required the DNA-binding domain of p50 and the transcription activation domain of C/EBP beta.File | Dimensione | Formato | |
---|---|---|---|
1996 Regulation of HIV-1 Long Terminal Repeats.pdf
non disponibili
Descrizione: 1996. THE JOURNAL OF BIOLOGICAL CHEMISTRY
Tipologia:
Documento in Post-print
Licenza:
Dominio pubblico
Dimensione
429.71 kB
Formato
Adobe PDF
|
429.71 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.